These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28677427)

  • 1. CUL4A as a marker and potential therapeutic target in multiple myeloma.
    Yang Y; Wang S; Li J; Qi S; Zhang D
    Tumour Biol; 2017 Jul; 39(7):1010428317703923. PubMed ID: 28677427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
    Li X; Xu R; Liu H; Fang K
    Tumour Biol; 2016 Jun; 37(6):8139-44. PubMed ID: 26715273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway.
    Deng J; Lei W; Xiang X; Zhang L; Lei J; Gong Y; Song M; Wang Y; Fang Z; Yu F; Feng M; Sun Z; Chen J; Zhan Z; Xiong J
    Oncotarget; 2016 Mar; 7(9):10037-50. PubMed ID: 26840256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the role of cullin 4A overexpression in human liver cancer.
    Chen G; Zhao X; Tan Z; Wang D; Luo D; Zhang P; Cao J; Wang F; Liu Q; Li L
    Mol Med Rep; 2018 Sep; 18(3):2531-2540. PubMed ID: 30015884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of CUL4A inhibits invasion and induces apoptosis in osteosarcoma cells.
    Song J; Zhang J; Shao J
    Int J Immunopathol Pharmacol; 2015 Jun; 28(2):263-9. PubMed ID: 26055549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CUL4A functions as an oncogene in ovarian cancer and is directly regulated by miR-494.
    Han X; Fang Z; Wang H; Jiao R; Zhou J; Fang N
    Biochem Biophys Res Commun; 2016 Nov; 480(4):675-681. PubMed ID: 27983981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CUL4A facilitates hepatocarcinogenesis by promoting cell cycle progression and epithelial-mesenchymal transition.
    Pan Y; Wang B; Yang X; Bai F; Xu Q; Li X; Gao L; Ma C; Liang X
    Sci Rep; 2015 Nov; 5():17006. PubMed ID: 26593394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentivirus-mediated short hairpin RNA interference of CENPK inhibits growth of colorectal cancer cells with overexpression of Cullin 4A.
    Li X; Han YR; Xuefeng X; Ma YX; Xing GS; Yang ZW; Zhang Z; Shi L; Wu XL
    World J Gastroenterol; 2022 Oct; 28(37):5420-5443. PubMed ID: 36312839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of CUL4A in human prostate cancer.
    Liu G; Zhu Z; Lang F; Li B; Gao D
    Tumour Biol; 2015 Nov; 36(11):8553-8. PubMed ID: 26036759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CUL4A regulates endometrial cancer cell proliferation, invasion and migration by interacting with CSN6.
    Wang X; Chen T
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma.
    Zhang TJ; Xue D; Zhang CD; Zhang ZD; Liu QR; Wang JQ
    World J Gastroenterol; 2017 Apr; 23(13):2318-2329. PubMed ID: 28428711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CUL4A overexpression as an independent adverse prognosticator in intrahepatic cholangiocarcinoma.
    Huang G-; Liu TT; Weng SW; You HL; Wei YC; Chen CH; Eng HL; Huang WT
    BMC Cancer; 2017 Jun; 17(1):395. PubMed ID: 28576144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CUL4A overexpression enhances lung tumor growth and sensitizes lung cancer cells to erlotinib via transcriptional regulation of EGFR.
    Wang Y; Zhang P; Liu Z; Wang Q; Wen M; Wang Y; Yuan H; Mao JH; Wei G
    Mol Cancer; 2014 Nov; 13():252. PubMed ID: 25413624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation.
    Huo X; Li S; Shi T; Suo A; Ruan Z; Guo H; Yao Y
    Oncotarget; 2015 Dec; 6(39):41959-75. PubMed ID: 26544623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of DACH1 activity by short hairpin RNA represses cell proliferation and tumor invasion in pancreatic cancer.
    Bu XN; Qiu C; Wang C; Jiang Z
    Oncol Rep; 2016 Aug; 36(2):745-54. PubMed ID: 27278537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. siRNA-mediated silencing of bFGF gene inhibits the proliferation, migration, and invasion of human pituitary adenoma cells.
    Zhou K; Fan YD; Duysenbi S; Wu PF; Feng ZH; Qian Z; Zhang TR
    Tumour Biol; 2017 Jun; 39(6):1010428317704805. PubMed ID: 28656882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
    Zhang HR; Chen JM; Zeng ZY; Que WZ
    J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIP2A regulates proliferation and apoptosis of multiple myeloma cells.
    Zheng Z; Qiao Z; Chen W; Gong R; Wang Y; Xu L; Ma Y; Zhang L; Lu Y; Jiang B; Li G; Dong C
    Mol Med Rep; 2016 Sep; 14(3):2705-9. PubMed ID: 27484817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of c-Met inhibits cell proliferation and invasion and increases chemosensitivity to doxorubicin in human multiple myeloma U266 cells in vitro.
    Que W; Chen J
    Mol Med Rep; 2011; 4(2):343-9. PubMed ID: 21468575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of interleukin 16 in multiple myeloma.
    Atanackovic D; Hildebrandt Y; Templin J; Cao Y; Keller C; Panse J; Meyer S; Reinhard H; Bartels K; Lajmi N; Sezer O; Zander AR; Marx AH; Uhlig R; Zustin J; Bokemeyer C; Kröger N
    J Natl Cancer Inst; 2012 Jul; 104(13):1005-20. PubMed ID: 22745469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.